Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

by Global Biodefense Staff October 7, 2020, 9:25 am
Yale’s COVID-19 Saliva Test Starts Roll Out to External Labs

by Global Biodefense Staff September 25, 2020, 7:06 am
Speed vs. Accuracy: Rapid Screening Tests Could Be Key to Ending the Pandemic

by Zoë McLaren, University of Maryland, Baltimore County August 14, 2020, 10:30 am
Abbott Releases Interim Data from Clinical Studies on ID NOW COVID-19 Diagnostic

by Global Biodefense Staff May 21, 2020, 8:22 am
National Science Foundation Backs Rapid Development of Portable, Saliva-Based COVID-19 Test

by Global Biodefense Staff May 7, 2020, 9:15 am
Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

by Global Biodefense Staff April 10, 2020, 8:02 pm
BARDA Funds Nanomix to Develop Rapid Mobile COVID-19 Diagnostics

by Global Biodefense Staff April 8, 2020, 2:00 pm
Cue Health Awarded Federal Contract for 25-Minute Nasal Swab COVID-19 Test

by Global Biodefense Staff March 31, 2020, 8:57 am
Cue Health Awarded $13 Million BARDA Contract for Development of Rapid SARS-CoV-2 Test

by Global Biodefense Staff March 31, 2020, 8:27 am
Abbott Receives EUA for Rapid Point-of-Care COVID-19 Diagnostic

by Global Biodefense Staff March 27, 2020, 10:38 pm
Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

by Global Biodefense Staff March 21, 2020, 10:27 am
Technology Accelerator Challenge: Non-Invasive, Handheld, Digital Diagnostic Device

by Global Biodefense Staff February 3, 2020, 8:27 pm
Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance

by Global Biodefense Staff January 31, 2020, 8:55 am
German Researchers Develop 1st Test for New Coronavirus

by Global Biodefense Staff January 17, 2020, 3:01 pm

Congratulations. You've reached the end of the internet.

POC Diagnostics

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

Silicon Lab-on-a-chip Test Could Provide Cheaper, Portable Diagnostics

Far Too Few Rapid COVID-19 Tests Available in U.S. to Put a Dent in the Pandemic

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV

NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

Yale’s COVID-19 Saliva Test Starts Roll Out to External Labs

Speed vs. Accuracy: Rapid Screening Tests Could Be Key to Ending the Pandemic

Abbott Releases Interim Data from Clinical Studies on ID NOW COVID-19 Diagnostic

National Science Foundation Backs Rapid Development of Portable, Saliva-Based COVID-19 Test

Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

BARDA Funds Nanomix to Develop Rapid Mobile COVID-19 Diagnostics

Cue Health Awarded Federal Contract for 25-Minute Nasal Swab COVID-19 Test

Cue Health Awarded $13 Million BARDA Contract for Development of Rapid SARS-CoV-2 Test

Abbott Receives EUA for Rapid Point-of-Care COVID-19 Diagnostic

Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

Technology Accelerator Challenge: Non-Invasive, Handheld, Digital Diagnostic Device

Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance

German Researchers Develop 1st Test for New Coronavirus

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles